Assessing p97 as an Alzheimer's disease serum biomarker
Journal Journal of Alzheimer's Disease
Wilfred A. Jefferies1, Dara L. Dickstein1, Maki Ujiie1
1Biotechnology Laboratory and the Biomedical Research Centre,
Departments of Medical Genetics,
Microbiology and Immunology and Zoology,
University of British Columbia, Canada
Abstract
The search is ongoing for a reliable serum biomarker for AD.
The level of iron is elevated in the brain of Alzheimer's disease (AD)
patients.
Our studies have demonstrated that the level of the iron transport
protein, p97,
is increased in the serum of AD patients but not in various control
groups.
These results have recently been confirmed by another laboratory who
extended our findings by demonstrating that p97 is not elevated in
other
neurodegenerative diseases.
This qualifies p97 as a potentially powerful biomarker for AD.
Although the relationship between increased level of iron and p97 in
the
AD brain is not well understood, our research supports the hypothesis
that
p97 over-expressed by senile plaque associated reactive microglia is
exocytosed and appears in blood.
The relationship between elevated levels of serum p97 and AD,
together
with the possible future clinical application of p97 are considered in
this report.
Journal Journal of Alzheimer's Disease
Publisher IOS Press
ISSN 1387-2877 (Print) 1875-8908 (Online)
Issue Volume 3, Number 3/2001
Pages 339-344
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh
Man Is A Herbivore!
http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
ironjustice - 04 Apr 2009 17:06 GMT
On Apr 3, 6:46 pm, ironjustice <ironjust...@gawab.com> wrote:The level
of iron is elevated in the brain of Alzheimer's disease <<
Abnormalities in oxidative processes in non-neuronal tissues
from patients with Alzheimer's disease
Journal Journal of Alzheimer's Disease
Gary E. Gibson1, Hui Zhang1
1Weil Medical College of Cornell University,
Burke Medical Research Institute,
785 Mamaroneck Avenue,
White Plains, NY 10605, USA
Abstract
Overwhelming evidence demonstrates that oxidative stress occurs
in brains from patients with Alzheimer's Disease (AD).
Whether the oxidative stress is secondary to neurodegeneration,
or if it underlies the pathology is not clear.
The persistence of AD-related abnormalities in oxidative processes
in non-neuronal tissues, including cultured cells, infers that an
imbalance in production and removal of reactive oxygen species is
an inherent property of cells from AD patients.
These results suggest that changes in oxidative processes in AD
cells could precede and/or cause AD-related neuropathology.
Abnormalities in oxidative processes may also cause changes in
signal transduction systems such as calcium that occur in cells from
AD patients.
The ability to manipulate oxidative processes in peripheral tissues,
especially cultured cells, from AD patients should facilitate a
mechanistic understanding of the changes in oxidative processes in
AD brain.
The use of peripheral tissues has the potential to identify both
state
and trait dependent diagnostic markers, which could be used as
endpoints for selecting treatments or monitoring therapeutic
effectiveness.
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://tinyurl.com/2r2nkh
Man Is A Herbivore!
http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
> Assessing p97 as an Alzheimer's disease serum biomarker
> Journal Journal of Alzheimer's Disease
[quoted text clipped - 43 lines]
>
> DEAD PEOPLE WALKINGhttp://tinyurl.com/zk9fk